Literature DB >> 3209326

A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark.

F Olesen1.   

Abstract

The number of previous vaginal smear examinations in 428 patients who developed invasive cancer of the cervix was compared with previous screening in age- and area-matched controls. The average age was 53 years. There was a highly significant difference in the numbers who had never undergone screening, ie 55% of the cancer patients and 33% of the controls. Equally there was a highly significant difference between cases and controls in the number examined according to recommended guidelines for prophylactic examination. It was shown that about 40% of the cytological tests were done for gynaecological reasons, and it is probable that the number of false negatives among the cases was not negligible. Despite this, however, regular screening reduced the relative risk of cancer to about 0.25, compared with those never examined. When only symptomless patients were considered in the assessment of regular screening, the relative risk was reduced to 0.15 in patients screened every three years. Even the group which was screened more than five years previously had a relative reduction in risk to 0.67, compared with those never screened. It is concluded that PAP-smears are important in the prevention of cancer of the cervix. The greatest need is to eliminate the group which is never examined. An increase in the number of screenings has only a marginal benefit.

Entities:  

Mesh:

Year:  1988        PMID: 3209326     DOI: 10.1093/ije/17.3.501

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

1.  Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up.

Authors:  W J Melchers; J M Bakkers; J Wang; P C de Wilde; H Boonstra; W G Quint; A G Hanselaar
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  [Histopathology of squamous cell carcinoma and adenocarcinoma of the uterine cervix].

Authors:  D Schmidt; L-C Horn; F Kommoss
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

3.  A population-based evaluation of cervical screening in the United States: 2008-2011.

Authors:  Jack Cuzick; Orrin Myers; William C Hunt; Michael Robertson; Nancy E Joste; Philip E Castle; Vicki B Benard; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-03       Impact factor: 4.254

4.  Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.

Authors:  Alejandra Castanon; Aruna Kamineni; K Miriam Elfström; Anita W W Lim; Peter Sasieni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-14       Impact factor: 4.254

5.  Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.

Authors:  H Mitchell; G Medley; I Gordon; G Giles
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

6.  Impact of screening on cervical cancer incidence: A population-based case-control study in the United States.

Authors:  Rebecca Landy; Peter D Sasieni; Christopher Mathews; Charles L Wiggins; Michael Robertson; Yolanda J McDonald; Daniel W Goldberg; Isabel C Scarinci; Jack Cuzick; Cosette M Wheeler
Journal:  Int J Cancer       Date:  2019-12-31       Impact factor: 7.316

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.